130 related articles for article (PubMed ID: 11734713)
1. Risk factors for human immunodeficiency virus infection in Ethiopian children with tuberculosis.
Palme IB; Gudetta B; Degefu H; Bruchfeld J; Muhe L; Giesecke J
Pediatr Infect Dis J; 2001 Nov; 20(11):1066-72. PubMed ID: 11734713
[TBL] [Abstract][Full Text] [Related]
2. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis.
Palme IB; Gudetta B; Bruchfeld J; Muhe L; Giesecke J
Pediatr Infect Dis J; 2002 Nov; 21(11):1053-61. PubMed ID: 12442029
[TBL] [Abstract][Full Text] [Related]
3. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
4. A controlled estimate of the risk of HIV infection in Ethiopian children with tuberculosis.
Berggren Palme I; Gudetta B; Degefu H; Muhe L; Bruchfeld J; Giesecke J
Epidemiol Infect; 2001 Dec; 127(3):517-25. PubMed ID: 11811886
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human immunodeficiency virus infection in a cohort of tuberculosis patients at Metema Hospital, Northwest Ethiopia: a 3 years retrospective study.
Tarekegne D; Jemal M; Atanaw T; Ebabu A; Endris M; Moges F; Tessema B; Deressa T
BMC Res Notes; 2016 Mar; 9():192. PubMed ID: 27026410
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis and HIV co-infections in Jamaican children.
Geoghagen M; Farr JA; Hambleton I; Pierre R; Christie CD
West Indian Med J; 2004 Oct; 53(5):339-45. PubMed ID: 15675501
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
9. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
10. Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire.
Froehlich H; Ackerson LM; Morozumi PA;
Pediatrics; 2001 Apr; 107(4):E54. PubMed ID: 11335775
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis.
Chintu C; Bhat G; Luo C; Raviglione M; Diwan V; Dupont HL; Zumla A
Pediatr Infect Dis J; 1993 Jun; 12(6):499-504. PubMed ID: 7688450
[TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children.
Besnard M; Sauvion S; Offredo C; Gaudelus J; Gaillard JL; Veber F; Blanche S
Pediatr Infect Dis J; 1993 Dec; 12(12):993-7. PubMed ID: 8108227
[TBL] [Abstract][Full Text] [Related]
13. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection.
Arbeláez MP; Nelson KE; Muñoz A
Int J Epidemiol; 2000 Dec; 29(6):1085-91. PubMed ID: 11101552
[TBL] [Abstract][Full Text] [Related]
14. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of HIV infection among paediatric tuberculosis patients in Agra, India: a hospital-based study.
Hussain T; Sinha S; Talan S; Verma S; Yadav VS; Dayal R; Sengupta U; Katoch VM
Tuberculosis (Edinb); 2007 Jan; 87(1):7-11. PubMed ID: 16901756
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort.
Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
Infect Dis Poverty; 2016 Nov; 5(1):96. PubMed ID: 27802839
[TBL] [Abstract][Full Text] [Related]
17. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
[TBL] [Abstract][Full Text] [Related]
18. HIV, BCG and TB in children: a case control study in Lusaka, Zambia.
Bhat GJ; Diwan VK; Chintu C; Kabika M; Masona J
J Trop Pediatr; 1993 Aug; 39(4):219-23. PubMed ID: 8411315
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with latent tuberculosis infection in Mexican American children.
Young J; O'Connor ME
Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
